Skip to main content
Premium Trial:

Request an Annual Quote

Baylor Genetics Neurodevelopmental Disorders Panel

Baylor Genetics has launched its Neurodevelopmental Disorders Panel for patients with suspected or clinically diagnosed autism spectrum disorder, intellectual disability, or developmental delay. The next-generation sequencing-based panel analyzes a set of 236 genes on an exome carvout and detects nucleotide variants, insertions and deletions, and copy number variants at "exceptional read depths," the laboratory said.